SA55 Injection: a Potential Therapy for the Prevention and Treatment of COVID-19
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT06050460 |
|
Recruitment Status :
Recruiting
First Posted : September 22, 2023
Last Update Posted : September 22, 2023
|
Sponsor:
Sinovac Life Sciences Co., Ltd.
Information provided by (Responsible Party):
Sinovac Biotech Co., Ltd ( Sinovac Life Sciences Co., Ltd. )
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | October 30, 2023 |
| Estimated Study Completion Date : | December 30, 2023 |